Novo Nordisk and Valo Health Bolster Partnership with $4.6 Billion Investment in Heart Metabolism Drug Development - AI

7 x 24 Track global technological trends

Hot Topic

Day

News Topic

Novo Nordisk and Valo Health Bolster Partnership with $4.6 Billion Investment in Heart Metabolism Drug Development

2025-01-09

The Danish pharmaceutical giant Novo Nordisk and the AI-driven biotech company Valo Health have announced an enhanced collaboration to jointly propel 20 novel drug projects focusing on cardiovascular diseases, obesity, and type 2 diabetes. The goal is to expedite the development of groundbreaking treatments for heart metabolism disorders. Pursuant to the agreement, Valo stands to receive cumulative milestone payments of approximately $4.6 billion, in addition to other research and development funding and royalties.

Previous page：Microsoft Pulls Bing Image Creator Model Amid User...

Next page：LG and Samsung Integrate Microsoft's Copilot AI As...

Return to List

Hot Reading

2 day ago

Security flaws in a carmaker’s web portal let one hacker remotely unlock cars from anywhere

2 day ago

AI Designs Super Safe Sub for Billionaires to Ride Into the Depths of the Ocean

1 day ago

Grok Is So Deeply Antisemitic That Showing It a Picture of Some Random Clouds in the Sky Prompts an Outrageously Offensive Answer

1 day ago

All the pains of Intel: from CPU design and process technologies to internal clashes and political pressure